- News>
- Companies & Commodities
US FDA approves Ranbaxy`s hypertension drug
New Delhi, Feb 12: The United States Food and Drug Administration (US FDA) has approved pharma giant Ranbaxy Laboratories Ltd`s Benazepril Hydrochloride tablets, the generic form of Novartis` Lotensin for hypertension.
New Delhi, Feb 12: The United States Food and Drug Administration (US FDA) has approved pharma giant Ranbaxy Laboratories Ltd's Benazepril Hydrochloride tablets, the generic form of Novartis' Lotensin for hypertension.
The city-based drugmaker is among seven firms, which received approval for generic equivalents of the generic formulation.
The US FDA announced the approval in the United States yesterday.
Bureau Report
The city-based drugmaker is among seven firms, which received approval for generic equivalents of the generic formulation.
The US FDA announced the approval in the United States yesterday.
Bureau Report